Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) announced earnings for its full year that Increased, from the same period last year
The company's bottom line totaled RMB120.285 million, or RMB0.0634 per share. This compares with RMB101.381 million, or RMB0.0533 per share, last year.
The company's revenue for the period fell 6.8% to RMB5.619 billion from RMB6.032 billion last year.
Guizhou Xinbang Pharmaceutical Co., Ltd. earnings at a glance (GAAP) :
-Earnings: RMB120.285 Mln. vs. RMB101.381 Mln. last year.-EPS: RMB0.0634 vs. RMB0.0533 last year.-Revenue: RMB5.619 Bln vs. RMB6.032 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.